BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37489928)

  • 21. Positron emission tomography in mantle cell lymphoma.
    Brepoels L; Stroobants S; De Wever W; Dierickx D; Vandenberghe P; Thomas J; Mortelmans L; Verhoef G; De Wolf-Peeters C
    Leuk Lymphoma; 2008 Sep; 49(9):1693-701. PubMed ID: 18798104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective head-to-head comparison of the Lugano classification and PERCIST for FDG-PET/CT response assessment in diffuse large B-cell lymphoma.
    Nielsen NB; Gerke O; Nielsen AL; Juul-Jensen K; Larsen TS; Møller MB; Hildebrandt MG
    Clin Physiol Funct Imaging; 2024 Jan; 44(1):70-78. PubMed ID: 37501554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
    Bodet-Milin C; Touzeau C; Leux C; Sahin M; Moreau A; Maisonneuve H; Morineau N; Jardel H; Moreau P; Gallazini-Crépin C; Gries P; Gressin R; Harousseau JL; Mohty M; Moreau P; Kraeber-Bodere F; Le Gouill S
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1633-42. PubMed ID: 20428863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological picture. FDG-PET in meningeal lymphomatosis.
    Shinohara M; Kosaka S; Okamura T; Yamamoto T
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):974. PubMed ID: 17702776
    [No Abstract]   [Full Text] [Related]  

  • 25. CXCR4 PET imaging of mantle cell lymphoma using [
    Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A
    Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma.
    Alavi A; Shrikanthan S; Aydin A; Talanow R; Schuster S
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):261-6. PubMed ID: 21658653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Giant Cell Tumor of the Tendon Sheath With Discordant Metabolism as a False Positive on Staging of Mantle Cell Lymphoma.
    Rezaee A; Chen W; Dilsizian V; Chen Q; Kimball AS
    Clin Nucl Med; 2015 Oct; 40(10):814-5. PubMed ID: 26053722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma.
    Zhou S; Chen W; Lin M; Chen G; Chen C; Huo C; Du X
    J Int Med Res; 2021 Jul; 49(7):3000605211029809. PubMed ID: 34250823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
    Kumar R; Bhargava P; Zhuang H; Yu JQ; Schuster SJ; Alavi A
    Clin Nucl Med; 2004 Nov; 29(11):685-8. PubMed ID: 15483478
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.
    Bilici A; Ustaalioglu BB; Seker M; Canpolat N; Gumus M
    Clin Nucl Med; 2010 Mar; 35(3):211-2. PubMed ID: 20173464
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
    Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
    JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
    Zhou X; Li Y; Wang Q
    Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma.
    Rajamäki A; Kuitunen H; Sorigue M; Kokkonen SM; Kuittinen O; Sunela K
    Cancer Med; 2023 Jan; 12(1):407-411. PubMed ID: 35661431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple metabolic parameters and visual assessment of
    Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
    Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting the accuracy of
    Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
    Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
    Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N
    Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.